Tanruprubart (ANX005) is a monoclonal antibody that blocks the activation of the entire classical signaling pathway by inhibiting complement protein C1q, which is upstream of the complement cascade reaction, while also maintaining the functional integrity of other complement pathways. It can be used in studies related to Guillain-Barre Syndrome (GBS).
Purity:
99.0%
CAS Number:
[2065212-40-8]
Target:
Complement System
* VAT and and shipping costs not included. Errors and price changes excepted
